Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (331-340 of 958) with videos related to

Pageof 96
Sort By:
The European Respiratory Journal|March 25, 2014
The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophiliaHector Ortega, Geoffrey Chupp, Philip Bardin, et al.
Respiration; International Review of Thoracic Diseases|August 15, 2012
Out-of-proportion pulmonary hypertension and heart failure with preserved ejection fractionYochai Adir, Marc Humbert, Olivier Sitbon, et al.
ERJ Open Research|July 9, 2024
Transition of care from adolescence to early adulthood in severe asthmatic patients treated with omalizumab in real lifeCamille Taillé, Marc Humbert, Arnaud Bourdin, et al.
Circulation|April 25, 2012
Mediastinal fibrosis mimicking proximal chronic thromboembolic diseaseAndrei Seferian, Xavier Jaïs, Nicolas Creuze, et al.
AJR. American Journal of Roentgenology|June 23, 2004
Pulmonary hypertension: CT of the chest in pulmonary venoocclusive diseaseArnaud Resten, Sophie Maitre, Marc Humbert, et al.
Blood Reviews|September 8, 2024
Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPHJean Escal, Geraldine Poenou, Xavier Delavenne, et al.
American Journal of Respiratory Cell and Molecular Biology|March 28, 2025
Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited - A Multigenerational PerspectiveGrazyna Kwapiszewska, Christopher Rhodes, Marlene Rabinovitch, et al.
Journal of the American College of Cardiology|September 3, 2002
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survivalOlivier Sitbon, Marc Humbert, Hilario Nunes, et al.
The European Respiratory Journal|March 25, 2022
Commemorating World Tuberculosis Day 2022: recent <i>ERJ</i> articles of critical relevance to ending TB and saving livesGiovanni Battista Migliori, Dennis Falzon, Guy B Marks, et al.
The European Respiratory Journal|June 20, 2020
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?Alice Huertas, David Montani, Laurent Savale, et al.
Pageof 96

Showing results (331-340 of 958) with videos related to

Sort By:
Pageof 96
The European Respiratory Journal|March 25, 2014
The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophiliaHector Ortega, Geoffrey Chupp, Philip Bardin, et al.
Respiration; International Review of Thoracic Diseases|August 15, 2012
Out-of-proportion pulmonary hypertension and heart failure with preserved ejection fractionYochai Adir, Marc Humbert, Olivier Sitbon, et al.
ERJ Open Research|July 9, 2024
Transition of care from adolescence to early adulthood in severe asthmatic patients treated with omalizumab in real lifeCamille Taillé, Marc Humbert, Arnaud Bourdin, et al.
Circulation|April 25, 2012
Mediastinal fibrosis mimicking proximal chronic thromboembolic diseaseAndrei Seferian, Xavier Jaïs, Nicolas Creuze, et al.
AJR. American Journal of Roentgenology|June 23, 2004
Pulmonary hypertension: CT of the chest in pulmonary venoocclusive diseaseArnaud Resten, Sophie Maitre, Marc Humbert, et al.
Blood Reviews|September 8, 2024
Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPHJean Escal, Geraldine Poenou, Xavier Delavenne, et al.
American Journal of Respiratory Cell and Molecular Biology|March 28, 2025
Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited - A Multigenerational PerspectiveGrazyna Kwapiszewska, Christopher Rhodes, Marlene Rabinovitch, et al.
Journal of the American College of Cardiology|September 3, 2002
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survivalOlivier Sitbon, Marc Humbert, Hilario Nunes, et al.
The European Respiratory Journal|March 25, 2022
Commemorating World Tuberculosis Day 2022: recent <i>ERJ</i> articles of critical relevance to ending TB and saving livesGiovanni Battista Migliori, Dennis Falzon, Guy B Marks, et al.
The European Respiratory Journal|June 20, 2020
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?Alice Huertas, David Montani, Laurent Savale, et al.
Pageof 96